Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 5/2010

01.05.2010 | Fertility Preservation

Using decision trees to enhance interdisciplinary team work: the case of oncofertility

verfasst von: Shauna L. Gardino, Jacqueline S. Jeruss, Teresa K. Woodruff

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Oncofertility, an emerging discipline at the intersection of cancer and fertility, strives to give cancer patients options when they are confronting potential infertility as a consequence of cancer treatment. Fertility preservation decisions must be made before treatment begins, adding stress to the decision-making process.

Methods

Healthcare providers need to be aware of the intricacies involved in oncofertility decision making, and the often tight time line that patients face when making these decisions. Cancer patient’s perspectives may also change, as the dual burden of a cancer diagnosis and potential infertility can cause great flux in emotions.

Results

A provider-facing decision tree was created to enhance patient decision-making capacities and outline the multiple potential intervention points.

Conclusions

Decision trees, which highlight the important decision points during which providers can approach patients, can be a useful tool to help providers in counseling patients on fertility preservation.
Literatur
1.
Zurück zum Zitat Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.CrossRefPubMed Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.CrossRefPubMed
2.
Zurück zum Zitat Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K, Picton HM, Plancha C, Shea LD, Stouffer RL, Telfer EE, Woodruff TK, Zelinski MB. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010. Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K, Picton HM, Plancha C, Shea LD, Stouffer RL, Telfer EE, Woodruff TK, Zelinski MB. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010.
3.
Zurück zum Zitat West ER, Zelinksi MB, Kondapalli LA, Gracia C, Chang J, Coutifaris C, et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer. 2009;53(2):289–95.CrossRefPubMed West ER, Zelinksi MB, Kondapalli LA, Gracia C, Chang J, Coutifaris C, et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer. 2009;53(2):289–95.CrossRefPubMed
4.
Zurück zum Zitat Nieman CL, Kinahan KE, Yount SE, Rosenbloom SK, Yost KJ, Hahn EA, Volpe T, Dilley KJ, Zoloth L, Woodruff TK. Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents. Nieman CL, Kinahan KE, Yount SE, Rosenbloom SK, Yost KJ, Hahn EA, Volpe T, Dilley KJ, Zoloth L, Woodruff TK. Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents.
5.
Zurück zum Zitat Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.CrossRefPubMed Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.CrossRefPubMed
6.
Zurück zum Zitat Woodruff TK. The emergence of a new interdiscipline: oncofertility. Cancer Treat Res. 2007;138:3011. Woodruff TK. The emergence of a new interdiscipline: oncofertility. Cancer Treat Res. 2007;138:3011.
7.
Zurück zum Zitat Zoloth L, Backhus L, Woodruff T. Waiting to be born: the ethical implications of the generation of “NUBorn” and “NUAge” mice from pre-pubertal ovarian tissue. Am J Bioeth. 2008;8(6):9.CrossRef Zoloth L, Backhus L, Woodruff T. Waiting to be born: the ethical implications of the generation of “NUBorn” and “NUAge” mice from pre-pubertal ovarian tissue. Am J Bioeth. 2008;8(6):9.CrossRef
8.
Zurück zum Zitat Guimerà R, Uzzi B, Spiro J, Amaral LA. Team assembly mechanisms determine collaboration network structure and team performance. Science. 2005;308(5722):697–702.CrossRefPubMed Guimerà R, Uzzi B, Spiro J, Amaral LA. Team assembly mechanisms determine collaboration network structure and team performance. Science. 2005;308(5722):697–702.CrossRefPubMed
9.
Zurück zum Zitat Dolin G, Roberts DE, Rodriguez LM, Woodruff TK. Medical hope, legal pitfalls: potential legal issues in the emerging field of oncofertility. Santa Clara Law Rev. 2009;49(3):673–716. Dolin G, Roberts DE, Rodriguez LM, Woodruff TK. Medical hope, legal pitfalls: potential legal issues in the emerging field of oncofertility. Santa Clara Law Rev. 2009;49(3):673–716.
10.
Zurück zum Zitat Campo-Englestein L. Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation. J Clin Oncol. 2010; epub ahead of print. Campo-Englestein L. Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation. J Clin Oncol. 2010; epub ahead of print.
11.
Zurück zum Zitat Wutchy S, Jones BF, Uzzi B. The increasing dominance of teams in production of knowledge. Science. 2007;36(5827):1036–9. Wutchy S, Jones BF, Uzzi B. The increasing dominance of teams in production of knowledge. Science. 2007;36(5827):1036–9.
14.
Zurück zum Zitat Aleem IS, Jalal H, Aleem IS, Sheikh AA, Bhandari M. Clinical decision analysis: incorporating the evidence with patient preferences. Patient Prefer Adherence. 2009;3:21–4.PubMed Aleem IS, Jalal H, Aleem IS, Sheikh AA, Bhandari M. Clinical decision analysis: incorporating the evidence with patient preferences. Patient Prefer Adherence. 2009;3:21–4.PubMed
15.
Zurück zum Zitat Kidger J, Murdoch J, Donovan JL, Blazeby JM. Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJORG: An International Journal of Obstetrics & Gynecology, 116(4):511–-17. Kidger J, Murdoch J, Donovan JL, Blazeby JM. Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJORG: An International Journal of Obstetrics & Gynecology, 116(4):511–-17.
16.
Zurück zum Zitat Sainio C, Eriksson E, Lauir S. Patient participation in decision making about care: the cancer patient’s point of view. Cancer Nurs. 2001;24(3):172–9.CrossRefPubMed Sainio C, Eriksson E, Lauir S. Patient participation in decision making about care: the cancer patient’s point of view. Cancer Nurs. 2001;24(3):172–9.CrossRefPubMed
17.
Zurück zum Zitat Nanton V, Docherty A, Meystre C, Dale J. Finding a pathway: Information and uncertainty along the prostate cancer patient journey. Br J Health Psychol. 14(3):437–58. Nanton V, Docherty A, Meystre C, Dale J. Finding a pathway: Information and uncertainty along the prostate cancer patient journey. Br J Health Psychol. 14(3):437–58.
18.
Zurück zum Zitat Detsky AS, Naglie G, Krahn MD, Redelmeier DA, Naimark D. Primer on medical decision analysis: part 2—building a tree. Med Decis Making. 1997;17:126–35.CrossRefPubMed Detsky AS, Naglie G, Krahn MD, Redelmeier DA, Naimark D. Primer on medical decision analysis: part 2—building a tree. Med Decis Making. 1997;17:126–35.CrossRefPubMed
19.
Zurück zum Zitat Hunink MGM. In search of tools to aid logical thinking and communicating about medical decision making. Med Decis Making. 2001;21:267.PubMed Hunink MGM. In search of tools to aid logical thinking and communicating about medical decision making. Med Decis Making. 2001;21:267.PubMed
20.
Zurück zum Zitat Chian RC, Huang JY, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91(6):2391–8.CrossRefPubMed Chian RC, Huang JY, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91(6):2391–8.CrossRefPubMed
21.
Zurück zum Zitat Quinn GP, Vadaparampil ST, Jacobsen PB, Knapp C, Keefe DL, Bell GE. Frozen hope: fertility preservation for women with cancer. J Midwifery Women’s Health. 2010;55(2):175–80.CrossRef Quinn GP, Vadaparampil ST, Jacobsen PB, Knapp C, Keefe DL, Bell GE. Frozen hope: fertility preservation for women with cancer. J Midwifery Women’s Health. 2010;55(2):175–80.CrossRef
22.
Zurück zum Zitat Tempst HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin’s lymphoma patients. Hum Reprod. 2008;23:251–8.CrossRef Tempst HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin’s lymphoma patients. Hum Reprod. 2008;23:251–8.CrossRef
23.
Zurück zum Zitat Stahl O, Eberhard J, Jepson K, et al. Sperm DNA intergrity in testicular cancer patients. Human Reprod. 2006;21:3199–205.CrossRef Stahl O, Eberhard J, Jepson K, et al. Sperm DNA intergrity in testicular cancer patients. Human Reprod. 2006;21:3199–205.CrossRef
Metadaten
Titel
Using decision trees to enhance interdisciplinary team work: the case of oncofertility
verfasst von
Shauna L. Gardino
Jacqueline S. Jeruss
Teresa K. Woodruff
Publikationsdatum
01.05.2010
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 5/2010
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-010-9413-8

Weitere Artikel der Ausgabe 5/2010

Journal of Assisted Reproduction and Genetics 5/2010 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.